PEDIATRICS Vol. 101 No. 1 January 1998, p. e7
ELECTRONIC ARTICLE:
Is the Incidence of Appendicitis Reduced in Patients
With Sickle Cell Disease?
,
From the * Department of Pediatrics, Case Western Reserve
University, Rainbow Babies and Children's Hospital, Cleveland, Ohio;
Department of Surgery, University of South Carolina, School of
Medicine, Charleston, South Carolina; and § Division of Hematology,
Department of Medicine, University of Illinois College of Medicine,
Chicago, Illinois.
| |
ABSTRACT |
|---|
|
|
|---|
Background. Patients with sickle cell disease (SCD) often present with abdominal pain, usually attributable to vasoocclusion. Experience at a single institution suggested that appendicitis was a rare cause of abdominal symptoms in this population.
Objective. We sought to determine whether the incidence of appendicitis was significantly lower in patients with SCD than in the population at large.
Methods. A 17-year retrospective chart review was performed at Rainbow Babies and Children's Hospital, Cleveland, OH, to determine the approximate incidence of acute appendicitis (AA) in patients with SCD. In addition, we performed a statistical analysis comparing the incidence of AA among SCD patients enrolled in the Cooperative Study of Sickle Cell Disease with that in the general population.
Results. Only two patients with SCD with pathologically confirmed AA were identified among ~200 patients followed at our institution during a 17-year period (~3500 patient-years), yielding an incidence rate of 5.7 cases per 10 000 patient-years. Among 3765 patients with SCD enrolled in the Cooperative Study of Sickle Cell Disease followed for a mean of 5.3 years (19 886 patient-years), a maximum of 9 cases of AA were identified, yielding an incidence rate of 4.5 cases per 10 000 patient-years. Based on data from the National Hospital Discharge Survey of 1978 to 1981, the incidence rate of AA in the general population (0 to 44 years of age) is ~16 per 10 000 patient-years. Paired t test analysis demonstrated a highly significant difference (P < .001) when comparing the incidence of AA among patients enrolled in the Cooperative Study of Sickle Cell Disease and the population at large.
Conclusion. AA is an unusual event in patients with SCD. The likelihood of developing appendicitis in SCD patients is less than one third of that for the population at large. Conservative therapy is warranted in the large majority of patients with SCD who present with acute abdominal pain. Surgical exploration is best limited to patients with clear evidence of potential surgical pathology or progressive findings during a period of observation. The biologic basis of our findings remains unknown.
Key words: sickle cell disease, appendicitis.
Pain caused by microvascular occlusion is among the most
common clinical expressions of sickle cell disease
(SCD).1 Abdominal pain often represents a substantial
diagnostic challenge in this population of patients. Although most
often attributable to vasoocclusion, symptoms and signs may mimic acute
surgical processes, particularly appendicitis.2 In such
circumstances, patients may undergo surgical exploration, often
yielding no evidence of gross or microscopic pathology.
Anecdotal observations made by the senior pediatric surgeons at Rainbow
Babies and Children's Hospital over several decades suggest that acute
appendicitis (AA) is a rare event in children and adolescents with SCD.
These observations prompted us to review our single-institution
experience, as well as to perform a retrospective review of data
accumulated from a large multicenter study of the natural history of
SCD (Cooperative Study of Sickle Cell Disease, Phase I).3
We hypothesized that the incidence of AA is significantly lower in
patients with SCD than in the general population.
Observations at Rainbow Babies and Children's Hospital
We retrospectively reviewed a 17-year experience at our
institution, during which 12 patients were identified with a hospital discharge diagnosis of SCD and appendectomy. This period included an
estimated 3500 patient-years. Among the 12 patients identified, the
majority had incidental appendectomies at the time of other abdominal
operative procedures. Only 2 patients had pathologic evidence of AA
(approximate incidence of 5.7 cases per 10 000 patient-years).
Histologic findings in all other appendices studied were normal. The 2 patients with documented AA involved a 16-year old male with mild SCD,
and a 17-year old female receiving chronic transfusion therapy because
of cerebral vascular disease.
Cooperative Study of Sickle Cell Disease Data
This dataset included 3765 patients between birth and 82 years
of age, followed at 23 clinical centers between 1978 and 1988. Mean
length of follow-up was 5.3 years (± 2.0 years), representing 19 886
patient-years.4 Nine nonincidental appendectomies were performed among this group (nonincidental appendectomies were defined
as primary operative procedures performed in cases of suspected AA).
Unfortunately, in a majority of cases, pathologic data was unavailable
for review; hence, for the purposes of this study, all cases were
considered to represent AA, although it is likely that some appendices
would have been pathologically normal. The incidence of appendicitis in
this population is, therefore, Appendicitis in the General Population
The incidence of AA in the general population was calculated
using data accumulated by the National Hospital Discharge Survey of
1978-1981.5,6 This survey provides data on a
representative sample of discharge diagnoses recorded in all
short-stay, nonfederal hospitals in the United States. Data are
weighted to derive national estimates of disease incidence. Among
individuals 0 to 44 year of age (a range that closely approximates the
SCD population database), the incidence of appendicitis was ~16 cases
per 10 000 patient-years.5,6
Statistical Analysis
Comparison of the incidence of AA in the SCD population with
that of the general population using the paired t test
yielded a highly statistically significant difference
(P < .001). The likelihood of developing AA in
patients with SCD was less than one third of that of the population at
large.
Review of available data supports the hypothesis that the
occurrence of AA is substantially lower in patients with SCD than in
the general population. We were able to demonstrate this difference with a high degree of statistical significance.
The biologic basis for this observation is unknown and deserves
additional study. Possible considerations include alterations in the
immune/inflammatory response in patients with SCD, a decrease in
lymphoid tissue proliferation in the gastrointestinal tract leading to
a lower likelihood of obstruction of appendiceal lumen, and/or an
effect of prophylactic antibiotic therapy on gastrointestinal tract
flora.
It has been suggested that the incidence of AA is lower in the nonwhite
population, although precise data are not available. Addiss and
coworkers7 estimate that whites are ~1.5 times more likely to develop AA than nonwhites. However, this racial
difference does not appear to account for our findings.
Our observations have considerable implications in the approach to the
patient with SCD and acute abdominal pain. In the absence of florid and
clear evidence of potential surgical pathology, a cautious, expectant
approach seems warranted. Conservative treatment, including effective
pain management, hydration, and other supportive measures, appears
warranted in the majority of patients before contemplating surgical
intervention. Patients with SCD and intraabdominal vasoocclusion often
manifests signs suggesting surgical disease, ie, abdominal wall muscle
rigidity and distention.8 The potential for
overinterpretation of these findings in the SCD population exists,
particularly among physicians and surgeons with limited experience in
the treatment of children and adults with hemoglobinopathy. Although
relatively unusual, AA does occur in patients with SCD; hence,
progressive abdominal findings during the period of observation warrants consideration of AA or other surgical complications.
In summary, our observations and analysis of available data demonstrate
that AA is far less common in patients with SCD than in the population
at large. The biologic basis of our findings remains unknown.
![]()
INTRODUCTION
Top
Abstract
Introduction
Methods
Discussion
References
![]()
METHODS
Top
Abstract
Introduction
Methods
Discussion
References
4.5 cases per 10 000 patient-years.
![]()
DISCUSSION
Top
Abstract
Introduction
Methods
Discussion
References
| |
FOOTNOTES |
|---|
Received for publication Jun 2, 1997; accepted Aug 5, 1997.
Reprint requests to (B.B.) Division of General Academic Pediatrics, Rainbow Babies and Children's Hospital, 11100 Euclid Ave, Cleveland, OH 44106-6019.
| |
ABBREVIATIONS |
|---|
SCD, sickle cell disease. AA, acute appendicitis.
| |
REFERENCES |
|---|
|
|
|---|
- Emburg S. Sickle cell Disease. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 1995:623
- Platt OS, Dover GJ. Sickle cell disease. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Philadelphia, PA: WB Saunders; 1993:749-750
-
Koshy M,
Weiner SJ,
Miller ST,
Surgery and anesthesia in sickle
cell disease.
Blood.
1995;
86:3676-3684
[Abstract/Free Full Text] - Farber MD, Koshy M, Kinney TR, the Cooperative Study of Sickle Cell Disease Cooperative study of sickle cell disease. Demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis. 1985; 38:495[CrossRef][Medline]
- National Center for Health Statistics. Utilization of Short-stay Hospitals, United States, 1981 Annual Summary. Washington, DC: US GPO; 1983. Vital and Health Statistics, series 13, no 72
- National Center for Health Statistics. Surgical and Non-surgical Procedures in Short Stay Hospitals, United States, 1979. Washington, DC: US GPO; 1983. Vital and Health Statistics, series 13, no 70
-
Addiss D,
Shaffer N,
Fowler B,
Tauxe R
The epidemiology of
appendicitis and appendectomy in the United States.
Am J
Epidemiol.
1990;
132:910-925
[Abstract/Free Full Text] - Scott-Conner CE, Brunson CD. Surgery and anesthesia. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:811-815
Pediatrics (ISSN 0031 4005). Copyright ©1998 by the American Academy of Pediatrics
This article has been cited by other articles:
![]() |
B. A. Banks Postnatal Dexamethasone for Bronchopulmonary Dysplasia: A Systematic Review and Meta-analysis of 20 Years of Clinical Trials NeoReviews, February 1, 2002; 3(2): e24 - 34. [Full Text] |
||||
![]() |
L. L. Wright The Role of Follow-up in Randomized Controlled Trials NeoReviews, November 1, 2001; 2(11): e257 - 266. [Full Text] [PDF] |
||||
![]() |
J. M. Bakker, A. Kavelaars, P. J. G. H. Kamphuis, P. M. Cobelens, H. H. van Vugt, F. van Bel, and C. J. Heijnen Neonatal Dexamethasone Treatment Increases Susceptibility to Experimental Autoimmune Disease in Adult Rats J. Immunol., November 15, 2000; 165(10): 5932 - 5937. [Abstract] [Full Text] [PDF] |
||||
![]() |
E S Shinwell, M Karplus, D Reich, Z Weintraub, S Blazer, D Bader, S Yurman, T Dolfin, A Kogan, S Dollberg, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2000; 83(3): 177F - 181. [Abstract] [Full Text] |
||||
![]() |
V Kavvadia, A Greenough, G Dimitriou, and R Hooper Randomised trial of fluid restriction in ventilated very low birthweight infants Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 91F - 96. [Abstract] [Full Text] |
||||
![]() |
N V Subhedar, A J Bennett, S P Wardle, and N J Shaw More trials on early treatment with corticosteroids are needed BMJ, April 1, 2000; 320(7239): 941 - 941. [Full Text] |
||||
![]() |
T F Fok, K Lam, M Dolovich, P C Ng, W Wong, K L Cheung, and K W So Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1999; 80(3): 203F - 208. [Abstract] [Full Text] |
||||
![]() |
O. BAUD, V. ZUPAN, T. LACAZE-MASMONTEIL, and M. DEHAN Neurological adverse effects of early postnatal dexamethasone in very preterm infants Arch. Dis. Child. Fetal Neonatal Ed., March 1, 1999; 80(2): 158F - 158. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








